PURINERG SIGNAL 润色咨询

Purinergic Signalling

出版年份:2004 年文章数:668 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:5.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1102835, encodeId=43cf11028350d, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102836, encodeId=4ad811028360f, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539470, encodeId=b6845394e0a9, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    上传文章有什么要求?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1102835, encodeId=43cf11028350d, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102836, encodeId=4ad811028360f, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539470, encodeId=b6845394e0a9, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2021-12-28 小动量

    如何判断两种药物之间是协同作用还是相加作用?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1102835, encodeId=43cf11028350d, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:52 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102836, encodeId=4ad811028360f, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539470, encodeId=b6845394e0a9, content=3分边缘,希望能维持稳定,略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]
    2017-07-18 chenyuming

    3分边缘,希望能维持稳定,略有上升也不错。

    0

共5条页码: 1/1页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分